Occupational Asthma Reference

Park HS, Nahm DH, New occupational allergen in a pharmaceutical industry: serratial peptidase and lysozyme chloride, Ann Allergy Asthma Immunol, 1997;78:225-229,

Keywords: peptidase, Korea, enzyme, pharmaceutical, lysozyme, rhinitis, IgE, antibody

Known Authors

Hae-Sim Park, Korea Hae-Sim Park

If you would like to become a known author and have your picture displayed along with your papers then please get in touch from the contact page. Known authors can choose to receive emails when their papers receive comments.


BACKGROUND: Serratial peptidase and lysozyme are often used as anti-inflammatory agents. There have been very few documented cases of occupational allergy caused by these substances. We report a case of a pharmaceutical industry worker who developed occupational asthma and rhinitis caused by both serratial peptidase and lysozyme chloride.

OBJECTIVE: It is important to alert physicians to the possibility of occupational asthma when dealing with workers in the pharmaceutical industry.

METHOD AND RESULT: The patient had strong positive responses to peptidase and lysozyme extracts on skin-prick tests. Bronchoprovocation tests showed a dual asthmatic response to peptidase and an early asthmatic response to lysozyme. Serum specific IgE antibodies to peptidase and lysozyme were detected by enzyme-linked immunosorbent assay (ELISA). In order to further characterize the allergenic component of these extracts, sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotting studies were also performed. More than ten components ranging form 7.3 to 83.1 kD were found in peptidase extracts, and two IgE binding components (67, 10.9 kD) were detected within the lysozyme extracts.

CONCLUSION: These findings suggest that inhalation of peptidase and lysozyme can induce IgE-mediated bronchoconstrictions in an exposed worker

Full Text

Full text of this reference not available

Please Log In or Register to add the full text to this reference


Please sign in or register to add your thoughts.

Oasys and occupational asthma smoke logo